Aims: This review examines the links between human development and cancer overall and for specific types of cancer, as well as cancer-related risk-factors and outcomes, such as disability and life expectancy. Methods: To assess human development, the Human Development Index was utilized continuously and according to four levels (low, medium, high, very high), where the low and very high categories include the least and most developed countries, respectively. All studies that assessed aspects of the global cancer burden using this measure were reviewed. Results: Although the present cancer incidence burden is greater in higher Human Development Index countries, a greater proportion of the global mortality burden is observed in less developed countries, with a higher mean fatality rate in the latter countries. Further, the future cancer burden is expected to disproportionally affect less developed regions; in particular, it has been estimated that low and medium Human Development Index countries will experience a 100% and 81% increase in cancer incidence from 2008 to 2030, respectively. Disparities were also observed in risk factors and average health outcomes, such as a greater number of years of life lost prematurely and fewer cancer-related gains in life expectancy observed in lower versus higher Human Development Index settings. Conclusions: From a global perspective, there remain clear disparities in the cancer burden according to national Human Development Index scores. International efforts are needed to aid countries in social and economic transition in order to efficiently plan, implement and evaluate cancer control initiatives as a means to reduce the widening gap in cancer occurrence and survival worldwide.
Introduction
Cancer is a major cause of morbidity and mortality worldwide, with approximately 14 million new cases and eight million deaths occurring in 2012 [1] . The large burden is projected to increase, with a predicted 22 million new cancer cases and 13 million cancer-related deaths occurring annually by 2030 [1] . This increasing magnitude of cancer is a consequence of population growth and aging, but societal, economic and lifestyle changeslinked to increasing human development -are likely to additionally increase the scale and alter the profile of cancer in the next decades.
Previous research has identified a strong correlation between human development, or socioeconomic advancement, and cancer [2] [3] [4] . The current literature provides valuable evidence for decisionmaking and setting priorities for addressing the cancer burden, but it also raises questions regarding inequalities in risk and burden. In this review we summarize the links between the global cancer burden and human development, highlighting inequalities in the burden across levels of human development. In particular, we assess the relationship between human development and cancer overall and for specific types of cancers, as well as cancer-related risk-factors and outcomes, such as disability and life expectancy. In so doing, this review serves as a status report on cancer in relation to human development, and identifies key areas where future work should be focused.
Measuring the burden of cancer
To assess the global cancer burden, we considered studies that utilized data from regional, national or international cancer registries or estimates, such as Cancer Incidence in 5 Continents [5] and GlOBOCAn [1] . We present results for both cancer incidence and mortality in this review. Cancer incidence is the number of new cases in a specified population over a given period of time, whilst cancer mortality is the number of deaths in a specified population over a given period of time [3] . Both measures are utilized in this study in terms of the absolute number of new cases or deaths, as well as age-standardized rates [6, 7] .
Measuring human development
In order to assess human development in this review, we strictly assessed studies that utilized the Human Development Index (HDI), which is a long-standing summary measure developed by the United nations Development Programme (UnDP) [8] . The HDI is defined as the average achievement of the following three dimensions of human development: a long and healthy life (based on life expectancy at birth); being knowledgeable (based on mean and expected years of schooling); and having a decent standard of living (based on gross national income per capita) [8] . In order to assess disparities in the cancer burden and cancer-related factors and outcomes, the HDI was assessed according to four HDI levels (low, medium, high, very high), where the low HDI level included countries that are the least developed and the very high HDI level included the most developed countries. A global map of each country by HDI level in 2012 [8] is shown in Figure 1 .
The global cancer burden and human development
Overall, there is a strong, positive relationship between the overall global cancer incidence burden and the HDI for both sexes (Figure 2(a) ), which is largely due to societies increasingly adapting to the behaviours and built environment conventionally more prevalent in westernized countries [2] . Indeed, 41% of the estimated global cancer cases in 2012 occurred in very high HDI countries, compared to 28% in high HDI, 16% in medium HDI and 6% in low HDI countries [2] . Although the current cancer burden in terms of incidence disproportionally affects the most developed countries, countries currently categorized in the low or medium HDI levels will, in fact, experience the greatest proportional increase in the future cancer burden [3] ; in particular, it has been estimated that low and medium HDI countries will experience a 100% and 81% increase in cancer incidence from 2008 to 2030, respectively [4] . such forecasted projections underscore the necessity for targeted resource-dependent interventions in order to reduce the number of future cases, particularly in the developing world. In contrast, when the pattern of mortality across the HDI was assessed, the age-standardized mortality rates appeared to be broadly comparable across the four HDI levels (Figure 2(b) ). As a result, when the mortality to incidence ratio was calculated, a greater proportion of the global cancer mortality burden was found to occur in low and medium HDI countries [4] . Findings such as these highlight the wide level of inequality in cancer mortality globally, with lower HDI countries experiencing poorer survival prospects after diagnosis due to the limited availability of and access to early detection programs, essential cancer medicines [9] , cancer surgery [10] and radiotherapy facilities [11] .
The cancer transition with human development
As a country transitions socially, economically and behaviourally with increasing human development, the cancer profile also transitions with decreases in infection-related cancers offset by increases in industrialization-related cancers. This phenomenon is illustrated in Figure 3 , which shows the proportion of cancers wholly or partially related to infection or industrialization/lifestyle factors across time for norway, singapore, Colombia and Uganda -four countries that represent roughly the four levels of the HDI. When norway is specifically assessed, the proportion of cancers related to infection decreased as the country developed, from [8] .
looking at how human development levels affect cancer profiles, the most frequent cancers in the high and very high HDI countries are prostate, breast, colorectum and lung cancers [2] . Although breast, prostate and colorectal cancers have also become more common in low and medium HDI settings, there remains a large number of infection-related cancers as well, most notably cancers of the stomach, liver, cervix and oesophagus [2] . In terms of the global cancer mortality burden, lung cancer was the main contributor in both lower and higher HDI settings [3] . Cancers of the liver, stomach and oesophagus were the second to fourth largest contributors to cancer mortality in low and medium HDI countries, whereas in high and very high HDI countries colorectal, breast and stomach cancers were the most fatal conditions [3, 4] .
Site-specific cancers and human development
As the factors within human development affect cancer through complex and variable pathways, it is important to assess the cancer-specific relationships with the HDI. In Figure 4 we provide the rate ratio (RR) comparing the age-standardized incidence rate (AsR) in low HDI countries to the AsR in very high HDI countries for 27 cancer types using GlOBOCAn 2012 data [1] . As shown, Kaposi's sarcoma (RR=15.1), cervical cancer (RR=3.2), nasopharyngeal cancer (RR=2.5), oesophageal cancer (RR=1.5), liver cancer (RR=1.1) and lip/oral cavity cancer (RR=1.1) are all more prevalent in lower HDI countries; each of these cancers have been linked previously to infections and/ or poverty and thus it is unsurprising that these cancers continue to be a greater burden in the developing world [12] [13] [14] . Conversely, all other cancer types were found to have a RR of less than one, signifying a higher AsR in very high HDI countries compared to low HDI countries, with breast, prostate and colorectal cancer having RRs of 0.4, 0.3 and 0.2, respectively.
In order to explore in more depth the relationship between the HDI and specific cancer types, we examined four common cancers globally, the details of which are given in the following sections ( Figure 5 ).
Colorectal cancer
Colorectal cancer has long been considered a marker of human development as, in general, increases in its incidence have paralleled increases in the HDI over time [3, 15, 16] . In particular, the AsR was estimated to be at least six times higher in very high HDI countries compared to low HDI countries in both males and females [2] . similarly, a positive gradient for mortality was observed, though the estimated risk of death was similar in countries indexed with high or very high HDI [3, 16] . The fact that colorectal cancer disproportionally affects the higher levels of the HDI likely relates to the changes in the prevalence of lifestyle-related risk-factors linked to westernization, including alcohol consumption [17] [18] [19] , increased consumption of red and processed meats and refined carbohydrates [20] [21] [22] [23] [24] , obesity [25] , physical inactivity [26] [27] [28] and smoking [29, 30] .
Breast cancer
Female breast cancer is the only cancer that is highly frequent across all HDI levels, being among the five most common incident and prevalent cancers in each of the four HDI categories [3, 4, [31] [32] [33] . However, there remains a gradient, with the AsR being approximately three times higher in very high HDI countries compared to low HDI countries [2] . Increasing life expectancy, reproductive and hormone changes, and screening likely contribute to the increased incidence of breast cancer in higher HDI countries [34, 35] , in addition to increased prevalence of risk factors associated with westernization, such as obesity [31, 32] and alcohol consumption [32, 33] . The mortality gradient was observed to be less consistent, with the risk in high and very high HDI countries being higher than medium HDI countries [3] . Of all HDI levels, however, the risk of breast cancer death was highest in countries with low HDI, reflecting the poorer survival in these women, making it the leading cause of cancer death in women from these countries [3] .
Prostate cancer
Although a significant correlation was observed between prostate cancer incidence and the HDI [2, 36] , the AsR was, in fact, lower in medium HDI countries than in low HDI countries [2] , reflecting the higher susceptibility for prostate cancer among black ethnic populations [37] . In contrast, the substantially higher AsR in very high HDI populations corresponds with the availability and highly prevalent use of prostate-specific antigen testing [38] . As prostate-specific antigen testing has a much greater effect on incidence than on mortality, there is less variation in mortality rates worldwide [1] . As a result, a significant correlation between HDI and mortality was not observed, with risks broadly comparable across levels of the HDI [36] .
Cervical cancer
Despite cervical cancer being one of the most preventable forms of cancer, the global burden of this cancer varies widely across HDI levels. specifically, cervical cancer incidence is negatively associated with the HDI [2] , with the burden being highly concentrated in low HDI settings where it accounts for up to one-third of all neoplasms diagnosed in both sexes [39] . A similar, but stronger, pattern with HDI was observed for cervical cancer mortality, with one study suggesting a 0.2 increment in HDI could lead to a 20% decrease in the risk of cervical cancer incidence and a 33% decrease in the risk of cervical cancer mortality [40] . such large differences in cervical cancer incidence reflect barriers to cancer control in less developed societies where preventative and screening programs remain limited. Furthermore, the high level of mortality in low HDI settings reflects later diagnosis and poorer survival in these settings, linked to weak health infrastructures and limited access to and availability of cancer services.
cancer risk factors and human development
Despite the broad associations between cancer and the HDI described above, there remain a large number of risk factors that are more directly linked to the occurrence of cancer, such as tobacco and alcohol use [41, 42] , diet [22, 43, 44] , radiation [45] , sunlight [46, 47] , air pollution [48, 49] , obesity [50] and infectious agents [12] . In the following section we assess the importance of obesity versus infections in relation to the HDI.
Obesity
In a recent report from the International Agency for Research on Cancer, excess body fatness was considered a risk factor for the following cancer sites and types: oesophagus (adenocarcinoma), gastric cardiac, colon and rectum, liver, gallbladder, pancreas, breast cancer (postmenopausal), corpus uteri, ovary, kidney (renal cell), meningioma, thyroid and multiple myeloma [50] . When the relationship between excess weight, or obesity, and cancer was assessed using the HDI, disparities were observed where the attributable fraction (AF) was greater in countries with very high and high HDIs (approximately 5% each) compared to countries with medium (1.6%) or low (1.0%) HDIs [31] . When assessed by sex, the AF was observed to increase as the HDI increased for both males and females ( Figure 6) . A similar positive relationship with HDI was observed when the number of preventable cancers was assessed for males; however, for women, the number of preventable cancers was greatest for women from the very high and medium HDI levels [31] . With the global cancer burden strongly linked to increased levels of human development, it is clear that prevention programmes to control weight gain are needed in these regions. However, these findings also emphasize the need for a global effort to reduce the number of people with high BMIs as the continuation of current patterns of population weight gain will continue to increase the future cancer burden across all HDI levels [31] .
Infections
Infections are an important risk factor for cancer [12] , causing approximately 15% of cancers worldwide in 2012 [51] . When the proportion of cancers attributable to infections was assessed by HDI level, the AF was observed to be low in countries with very high HDI scores and high in countries with low HDI scores [51] . specifically, the AF due to infections was 25%, 22%, 13% and 8% in low HDI, medium HDI, high HDI and very high HDI countries, respectively [51] . When specific types of infections were assessed, human papillomavirus (HPV) was found to cause approximately half of all infection-attributable cancers in low HDI settings, with the proportion of infectionrelated cancers attributable to HPV decreasing with increasing human development [51] . Conversely, Helicobacter pylori was found to contribute substantially to the cancer burden in countries with high and very high HDIs [51] . With two-thirds of infectionattributable cancers occurring in developing countries in 2012, it is clear that population-based vaccination and screen-and-treat programmes should be prioritized and made in a cost-effective manner in order to combat the disproportionally high infection-related cancer burden in these countries [51] .
Impact of cancer and human development
With cancer contributing substantially to the global morbidity and mortality, it is important to assess the implications of cancer and the extent of cancer-related sequelae. Thus, we examine below the impact of cancer on disability post-diagnosis, as well as its overall impact on life expectancy, across HDI levels.
Disability-adjusted life years (DALYs)
To assess the impact of fatal and non-fatal cancer outcomes, one study calculated the DAlys globally by the HDI levels [52] . DAlys are a measure that can be utilized to determine the number of lost healthy years of life, which is calculated by summing the number of years of life lost (yll) due to premature mortality in the population with the number of years lost due to disability (ylD) for people living with cancer or its consequences. In this report, a fairly small difference in total DAlys lost between the four HDI subgroups was noted [52] . However, when the components of the DAlys were assessed, the contribution of ylls and ylDs varied substantially across HDI levels, with generally higher ylD totals observed in very high HDI countries and higher yll totals observed in lower HDI countries [52] . When the DAlys were assessed for specific cancer sites, lung, breast and colorectal cancers were the main contributors to the high DAly total in very high HDI countries, whereas cervical cancer, liver cancer and Kaposi's sarcoma were the largest contributors to the DAlys in low and medium HDI countries (Figure 7 ) [52] . Again, even when assessed by specific cancer sites, the ylDs were found to be main contributor to the DAlys in higher HDI countries whilst ylls were more important in lower HDI countries, though the extent of this relationship varied by the site of the cancer [52] . The fact that the fraction of DAlys due to ylls was consistently greater in lower HDI countries signifies the poorer prognosis of patients with cancer in developing countries, and highlights the need for substantial improvements in access to adequate cancer care in these countries.
Gains in life expectancy
When the impact of cancer on alternating overall life expectancy worldwide during the period was assessed, very high HDI countries observed larger improvements compared to medium/high HDI countries (medium and high HDIs were combined for all analyses described in this section) [53] . In particular, declining cancer mortality was responsible for improving the male and female life expectancy by 0.8 and 0.5 years, respectively, for individuals aged 40-84 years in very high HDI populations; the corresponding gains were 0.2 years for both males and females in medium/high HDI populations [53] . When the hypothetical situation of eliminating all cancer deaths was assessed for the period of 2006-2010, males and females aged 40-84 years in very high HDI population could gain 2.5 and 1.9 years in life expectancy, respectively; for medium/high HDI population, improvements were still observed but at lower levels, with 1.6 and 1.5 years gained in males and females, respectively [53] . Among males, the largest potential gain in life expectancy could be achieved through the elimination of lung cancer, with 0.4 potential life years gained in medium/high HDI populations and 0.7 potential life years gained in very high HDI populations [53] . Among females, the largest potential gain in life expected was achieved by eliminating breast cancer deaths; the potential gain in life years did not vary substantially, however, with 0.4 and 0.3 years gained in very high HDI populations and medium/ high HDI populations, respectively [53] . Again, these results provide evidence of disproportional improvements in cancer across HDI levels, which are leading to an increasing gap between less and more developed populations.
conclusion
This review has examined how changing levels of human development impact the scale and profile of cancer worldwide, highlighted the main drivers, and noted the implications of these inequalities on disability and life expectancy. Further, this review illustrates the need for global action and cost-effective cancer control strategies that can decelerate and diminish the widening gaps in the global cancer burden between the least and most developed countries in future decades.
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